| 25th Feb 2021 7:00 am |
EQS |
Board Changes |
| 15th Feb 2021 9:00 am |
EQS |
Holding(s) in Company |
| 11th Feb 2021 7:00 am |
EQS |
Notice of Results |
| 10th Feb 2021 9:00 am |
EQS |
Autolus announces pricing of public offering |
| 5th Feb 2021 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 5th Feb 2021 4:36 pm |
RNS |
Price Monitoring Extension |
| 5th Feb 2021 9:06 am |
RNS |
Second Price Monitoring Extn |
| 5th Feb 2021 9:00 am |
RNS |
Price Monitoring Extension |
| 18th Jan 2021 7:00 am |
EQS |
Investment team changes |
| 12th Jan 2021 7:00 am |
EQS |
Harpoon announces closing of public offering |
| 6th Jan 2021 2:00 pm |
EQS |
Imara reports Phase 2a clinical trial results of IMR-687 in adult patients with sickle cell disease |
| 6th Jan 2021 10:00 am |
EQS |
Autolus provides business outlook for 2021 and 2022 |
| 31st Dec 2020 9:00 am |
RNS |
Price Monitoring Extension |
| 21st Dec 2020 7:00 am |
EQS |
Director Share Purchase |
| 18th Dec 2020 8:00 am |
EQS |
Completion of sale of VelosBio |
| 11th Dec 2020 7:00 am |
EQS |
Atox Bio announces FDA acceptance of New Drug Application |
| 8th Dec 2020 3:45 pm |
EQS |
Harpoon reports clinical progress across all pipeline development programmes |
| 7th Dec 2020 5:48 pm |
EQS |
Autolus presents additional data on AUTO3 at ASH |
| 7th Dec 2020 7:15 am |
EQS |
Hardman & Co Research: Arix Bioscience (ARIX): Artios attracts Merck KGaA in deal up to $7bn |
| 7th Dec 2020 7:01 am |
EQS |
Autolus presents positive AUTO1 data at ASH |
| 4th Dec 2020 7:01 am |
EQS |
Holding(s) in Company |
| 4th Dec 2020 7:00 am |
EQS |
Holding(s) in Company |
| 3rd Dec 2020 9:05 am |
RNS |
Second Price Monitoring Extn |
| 3rd Dec 2020 9:00 am |
RNS |
Price Monitoring Extension |
| 3rd Dec 2020 8:01 am |
EQS |
Artios and Merck KGaA announce global strategic collaboration |
| 12th Nov 2020 7:00 am |
EQS |
Arix to Present at the Jefferies Virtual London Healthcare Conference |
| 6th Nov 2020 12:10 pm |
EQS |
Hardman & Co Research: Arix Bioscience (ARIX): Hitting the jackpot |
| 5th Nov 2020 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 5th Nov 2020 2:00 pm |
RNS |
Price Monitoring Extension |
| 5th Nov 2020 11:38 am |
EQS |
Arix Bioscience PLC: VelosBio to be acquired by Merck for $2.75 billion |
| 1st Oct 2020 2:40 pm |
EQS |
LogicBio announces pricing of public offering |
| 21st Sep 2020 11:20 am |
EQS |
Hardman & Co Research: Arix Bioscience (ARIX): Realising the valuation disconnect |
| 18th Sep 2020 8:57 am |
EQS |
Arix Bioscience PLC: Autolus presents additional AUTO3 data in DLBCL |
| 8th Sep 2020 7:00 am |
EQS |
Arix Bioscience PLC: Interim Results for the Six Months Ended 30 June 2020 |
| 13th Aug 2020 7:07 am |
PRN |
Notice of Results |
| 10th Aug 2020 12:49 pm |
PRN |
LogicBio announces IND clearance for LB-001 |
| 31st Jul 2020 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 31st Jul 2020 2:00 pm |
RNS |
Price Monitoring Extension |
| 31st Jul 2020 7:01 am |
PRN |
Total Voting Rights |
| 20th Jul 2020 1:28 pm |
PRN |
Amplyx announces positive Phase 2 data |
